Role of NR2B NMDA Receptors in Pain from Oxaliplatin in Rats
Author Information
Author(s): Mihara Yuki, Egashira Nobuaki, Sada Hikaru, Kawashiri Takehiro, Ushio Soichiro, Yano Takahisa, Ikesue Hiroaki, Oishi Ryozo
Primary Institution: Department of Pharmacy, Kyushu University Hospital
Hypothesis
The study investigates the involvement of NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats.
Conclusion
Spinal NR2B-containing NMDA receptors are involved in the mechanical allodynia caused by oxaliplatin.
Supporting Evidence
- Oxaliplatin administration caused mechanical allodynia in rats.
- NMDA receptor antagonists reversed the pain behavior induced by oxaliplatin.
- NR2B protein and mRNA levels increased in the spinal cord after oxaliplatin treatment.
Takeaway
When rats were given a chemotherapy drug called oxaliplatin, it made them feel pain when their paws were touched, and blocking certain receptors in their spine helped reduce that pain.
Methodology
Rats were treated with oxaliplatin and various NMDA receptor antagonists were administered to assess their effects on pain behavior using the von Frey test.
Limitations
The study was conducted on rats, which may not fully represent human responses.
Participant Demographics
Male Sprague-Dawley rats weighing 200-250 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website